J. Edenfield

Effects of ketoconazole and esomeprazole on the pharmacokinetics of pazopanib in patients with solid tumors

A. Tan, J. Botbyl, J. Stephenson, 2013, Cancer Chemotherapy and Pharmacology.

Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer

J. Baselga, M. Ranson, J. Schellens, 2018, Cancer Chemotherapy and Pharmacology.

Genomic profiling of cell-free circulating tumor DNA in patients with colorectal cancer and its fidelity to the genomics of the tumor biopsy.

J. Gregg, J. Hughes, V. Miller, 2019, Journal of gastrointestinal oncology.

LBA-003Phase 1b/II study of cancer stemness inhibitor napabucasin in combination with FOLFIRI +/- bevacizumab (bev) in metastatic colorectal cancer (mCRC) patients (pts).

A. Grothey, J. Bendell, H. Pitot, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Abstract B201: A phase 1 dose-finding study of X4P-001 (an oral CXCR4 inhibitor) and axitinib in patients with advanced renal cell carcinoma (RCC)

T. Ho, M. Atkins, U. Vaishampayan, 2018 .